Could a 14-Day pill lift Post-Stroke depression?
NCT ID NCT06759558
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a 14-day course of the oral drug zuranolone in 6 stroke survivors with moderate to severe depression. Researchers want to see if the drug is safe, well-tolerated, and improves mood. Participants take 50 mg daily and complete mood questionnaires and blood tests.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-STROKE DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke South Neurology Clinic 1L
RECRUITINGDurham, North Carolina, 27710-0400, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Acupuncture plus sedative may shield stroke survivors from depression
- Can a simple relaxation technique soothe the mind after a stroke?
- Zapping the brain to lift Post-Stroke depression?
- Video therapy aims to stop Post-Stroke depression in Low-Income seniors
- Can pressurized oxygen lift the fog of Post-Stroke depression?
- Could VR and a brain zapper lift Post-Stroke depression?